west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "全肺切除术" 11 results
  • 开窗换药治疗全肺切除术后气管残端瘘伴食管胸膜瘘一例

    Release date:2016-08-30 05:47 Export PDF Favorites Scan
  • 带蒂肋间肌瓣防治支气管胸膜瘘17例临床分析

    目的 探讨采用带蒂肋间肌瓣包埋支气管残端预防和治疗支气管胸膜瘘的临床意义,总结治疗经验。 方法  回顾性分析2001年10月至2009年6月重庆市江津中心医院对17例肺癌、肺结核伴支气管扩张、支气管扩张患者行肺切除术后采用带蒂肋间肌瓣包埋支气管残端的临床资料。14例为预防性治疗,男8例,女6例;年龄21~69岁;其中6例行全肺切除术,8例行肺叶切除术。3例行肺癌肺叶切除术后支气管胸膜瘘二期修补术,男2例,女1例;年龄58~68岁。 结果 预防性治疗14例患者,手术时间135~275 min,均治愈,无并发症;随访12例,随访时间6~60个月,随访期间无1例发生支气管胸膜瘘。3例肺癌术后支气管胸膜瘘接受带蒂肋间肌瓣治疗患者手术时间75~165 min,2例痊愈,1例同时行局部胸膜内胸廓成形术痊愈;3例均随访6~24个月,无1例再发支气管胸膜瘘。 结论  带蒂肋间肌瓣包埋支气管残端防治支气管胸膜瘘安全有效,尤其适用于肺切除术后支气管残端或吻合口的加固预防支气管胸膜瘘的发生。

    Release date:2016-08-30 05:56 Export PDF Favorites Scan
  • 补充性全肺切除术治疗肺癌

    目的评估补充性全肺切除术的适应证、危险性和结果. 方法回顾性分析49例残肺恶性病变患者的补充性全肺切除术,其中第二原发性肺癌14例,肺癌复发35例;再次手术平均间隔期为29个月. 结果全组死亡6例,1例死于术中,5例死于术后,手术死亡率为12.24%.术后随访1个月~5年,中位数生存时间2.5年,5年生存率为33%. 结论补充性全肺切除术治疗残肺癌,手术死亡率和术后5年生存率接近标准的全肺切除术.

    Release date:2016-08-30 06:31 Export PDF Favorites Scan
  • 兔一侧全肺切除术后血浆心钠素变化及意义

    目的 探讨心钠素(ANP)与肺切除术后心肺并发症的相关关系。 方法 将30只兔随机分为3组。组Ⅰ:12只,行左全肺切除术;组Ⅱ:12只,行右全肺切除术;对照组:6只,不行肺切除。3组术前、术后测血气分析,ANP,心肌酶和心电图监测,均不吸氧。 结果 组Ⅰ和组Ⅱ术后30分钟pH下降,动脉血氧分压(PaO2)下降,动脉血二氧化碳分压(PaCO2)升高;术后60分钟ANP升高,术后180分钟心肌酶升高,与术前比较差异均有显著性(P<0.05或P<0.01)。组Ⅰ和组Ⅱ有心律失常者的ANP与无心律失常者比较差异有显著性(P<0.01)。ANP与PaO2,肌酸激酶呈相关关系(r=-0.737,0.779,P<0.01)。 结论 兔一侧全肺切除术后ANP显著升高,可作为肺外科术后监测心肺并发症的无创指标之一。

    Release date:2016-08-30 06:33 Export PDF Favorites Scan
  • Coopdech支气管封堵器用于全肺切除术后对侧胸腔内手术三例

    目的探讨Coopdech支气管封堵器用于全肺切除术后对侧胸腔内手术麻醉的可行性及疗效。 方法回顾性分析上海市肺科医院2012年1~12月3例全肺切除术后患者需要进行对侧胸腔内手术时,在纤维支气管镜引导下置入Coopdech支气管封堵器隔离目标肺叶,进行选择性肺叶通气麻醉。比较3例患者封堵前后生命体征和血气分析。 结果3例患者均顺利完成手术,术中调整呼吸参数(封堵后,减少潮气量、增加呼吸频率)维持脉搏血氧饱和度(SpO2)大于96%、动脉血氧分压(PaO2)大于75 mm Hg、动脉血二氧化碳分压(PaCO2)35~45 mm Hg、pH值7.32~7.40,术中目标肺叶萎陷良好,给外科医生提供了良好的手术视野,术毕患者清醒拔管回ICU。 结论Coopdech支气管封堵器可以用于全肺切除术后对侧胸腔内手术的麻醉。

    Release date: Export PDF Favorites Scan
  • 儿童左肺囊肿伴感染行左全肺切除术肺隔离失败一例

    Release date: Export PDF Favorites Scan
  • Progress on Prevention and Treatment of Postpneumonectomy Complications

    Pneumonectomy is known as an effective treatment of lung cancer, lung tuberculosis, and damaged lung. But the incidences of complications and mortality are significantly higher in patients undergoing pneumonectomy than those undergoing lobectomy. The complication rate within 30 days after pneumonectomy is 11%-49% and the mortality is 3%-25%. Mortality of right pneumonectomy is triple that of left pneumonectomy. Postpneumonectomy complications include cardiopulmonary failure, bronchopleural fistula and postpneumonectomy syndrome. Besides the symptomatic treatment, which includes flushing drainage, plugging and operation, observation and prompt diagnosis are necessary for prevention. This review is focused on the prevention and treatment of complications after pneumonectomy.

    Release date: Export PDF Favorites Scan
  • Clinical analysis of pneumonectomy by video-assisted thoracoscopic surgery

    Objective To evaluate the validity of video-assisted thoracoscopic surgery (VATS) pneumonectomy in thoracic diseases treatment. Methods We retrospectively analyzed the clinical data of 34 consecutive patients who underwent VATS pneumonectomy in Xiangya Hospital Central South University between January 2013 and October 2015. There were 26 males and 8 females at age of 35–69 (53.8±7.7) years. Results VATS pneumonectomy was completed successfully in 32 patients (5.8% conversion rate). The average operation time was 182.5±52.4 min. The average blood loss was 217.1±1 834.8 ml. Chest tube drainage flow was 3–11 (6.0±1.7) days and postoperative hospital stay was 5–12 (7.6±1.8) days. Eleven patients got postoperative complications (34.3%), mainly pulmonary infections. The 32 patients were followed up for 10 (1–21) months. Two patients died of lung metastasis 16 or 17 months after the operation. One patient died of sudden cardiac arrest 3 months after operation. Bronchopleural fistula (BPF) happened in one patient after hospital discharge in 2 months. Conclusion VATS is feasible for pneumonectomy. However, further studies and follow-up are needed to verify the benefits of VATS pneumonectomy for lung cancer.

    Release date:2017-07-03 03:58 Export PDF Favorites Scan
  • Clinical comparison of two thoracic drainage methods after thoracoscopic pneumonectomy

    ObjectiveTo explore an effective and safe drainage method, by comparing open thoracic drainage and conventional thoracic drainage for lung cancer patients after thoracoscopic pneumonectomy.MethodsThe clinical data of 147 patients who underwent thoracoscopic pneumonectomy from January 2015 to March 2018 in our hospital were retrospectively analyzed, including 128 males and 19 females. Based on drainage methods, they were divided into an open drainage group (open group) and a conventional drainage group (regular group). The incidence of postoperative complications, chest tube duration, drainage volume at postoperative 3 days, postoperative hospital stay, hospitalization cost and quality of life were compared between the two groups.ResultsPostoperative complication rate was lower in the open group than that in the regular group (10.20% vs. 23.47%, P=0.04). The chest tube duration of the open group was longer compared with the regular group (5.57±2.36 d vs. 3.22±1.23 d, P<0.001). The drainage volume at postoperative 3 days was less in the regular group. In the open group, ambulation was earlier, thoracocentesis was less and re-intubation rate was lower (all P<0.001). The postoperative hospital stay in the regular group was significantly longer than that in the open group (8.37±2.56 d vs. 6.35±1.87 d, P<0.001) and hospitalization cost was significantly higher (66.2±5.4 thousand yuan vs. 59.6±7.3 thousand yuan, P<0.001). Besides, quality of life in 1 and 3 months after operation was significantly better than that in the open group (P<0.001).ConclusionCompared with the regular chest drainage, the effect of open thoracic drainage is better, which can help reduce postoperative complications, shorten the length of hospital stay, reduce the hospitalization cost and improve the quality of postoperative life. It is worthy of clinical promotion.

    Release date:2019-10-12 01:36 Export PDF Favorites Scan
  • Upper left lung cancer with congenital complete left pericardial defect: A case report

    A 54-year-old asymptomatic man underwent a video-assisted thoracoscopic left pneumonectomy for squamous-cell carcinoma. During the surgery, a complete left pericardial defect was unexpectedly discovered, but no special intervention was made. The preoperative chest CT was reciewed, which showed the heart extended unusually to the left, but the left pericardial defect was not evident. The operation time was 204 min and the patient was discharged from hospital upon recovery 9 days after the surgery. The pathological result indicated moderately differentiated squamous-cell carcinoma (T2N1M0, stage ⅡB), and metastasis was found in the parabronchial lymph nodes (3/5). The patient did not receive chemotherapy after the surgery, and there was no signs of recurrence 6 months after the surgery. Complete pericardial defects usually do not endanger the lives of patients, and if the patient is asymptomatic, pneumonectomy is feasible.

    Release date: Export PDF Favorites Scan
2 pages Previous 1 2 Next

Format

Content